Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is witnessing several developments as outlined in its latest quarterly income statement for the period ending March 31, 2025. Here’s a concise overview of the company's financial performance, highlighting key positives and negatives:
Positive Aspects:
...